logo

Theravance Biopharma Inc. (TBPH)



Trade TBPH now with
  Date
  Headline
11/9/2018 3:36:00 PM Theravance, Mylan Get FDA Approval For YUPELRI In Adults With Chronic Obstructive Pulmonary Disease
10/11/2018 8:32:20 AM Theravance Biopharma, Mylan Report Positive New Data From Multiple Studies Of YUPELRI At 2018 CHEST Annual Meeting
10/10/2018 8:35:41 AM Theravance Biopharma Announces Data From Phase 1b Study Of TD-1473 Selected For Oral Late-Breaker Presentation At UEG
10/8/2018 8:33:51 AM Theravance Biopharma And Mylan To Present New Data From Studies Of YUPELRI
10/8/2018 7:31:50 AM Theravance Biopharma Reports Positive New Data From Multiple Studies Of VIBATIV At IDWeek 2018
9/17/2018 8:33:09 AM Theravance Biopharma And Mylan Report New Data From Phase 3 Studies Of YUPELRI
4/25/2018 8:38:53 AM Theravance Biopharma Highlight That FDA Approved Expanded Indication For Trelegy Ellipta
4/17/2018 8:32:54 AM Theravance Biopharma To Present New Data From Multiple Studies Of VIBATIV At 2018 ECCMID™ Conference
2/7/2018 7:34:03 AM Theravance Biopharma Enters Global Collaboration With Janssen For TD-1473 In Inflammatory Intestinal Diseases